Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avenue Therapeutics Inc.

0.2651
-0.0115-4.16%
Volume:1.38K
Turnover:379.64
Market Cap:544.39K
PE:-0.03
High:0.2800
Open:0.2800
Low:0.2651
Close:0.2766
Loading ...

Company Profile

Company Name:
Avenue Therapeutics Inc.
Exchange:
PINK
Establishment Date:
2015
Employees:
2
Office Location:
1111 Kane Concourse,Suite 301,Bay Harbor Islands,Florida,United States
Zip Code:
33154
Fax:
- -
Introduction:
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes therapies for the treatment of rare and neurologic diseases in the United States. Its lead product candidate includes AJ201, which in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous (IV) Tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. Avenue Therapeutics, Inc. was incorporated in 2015 and is based in Tampa, Florida.